Sign in

CIK 0001642380

  • Non-accelerated filer
  • Smaller reporting company

Insight Molecular Diagnostics Inc.

Sign in to watch
Ticker
IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
271041563
Phone
+1 949-409-7600
Business address
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Former names
OncoCyte Corp, Oncocyte Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 23 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-26 James Andrea S. Chief Financial Officer Exercise or conversion +28,302 217,358
2026-03-26 James Andrea S. Chief Financial Officer Shares withheld for taxes −11,298 $4.11 $46K 206,060
2026-03-26 James Andrea S. Chief Financial Officer Exercise or conversion · Restricted Stock Units −28,302 84,905
2025-10-31 James Andrea S. Chief Financial Officer Exercise or conversion +50,000 201,231
2025-10-31 James Andrea S. Chief Financial Officer Shares withheld for taxes −12,175 $6.01 $73K 189,056
2025-10-31 James Andrea S. Chief Financial Officer Exercise or conversion · Restricted Stock Units −50,000 50,000
2025-10-31 James Andrea S. Chief Financial Officer Exercise or conversion +50,000 201,231
2025-10-31 James Andrea S. Chief Financial Officer Returned to the company · Restricted Stock Units +50,000 50,000
2025-09-28 James Andrea S. Chief Financial Officer Grant or award · Option to Purchase Common Stock +235,000 235,000
2025-03-26 James Andrea S. Chief Financial Officer Grant or award · Restricted Stock Units +113,207 113,207
2025-02-07 James Andrea S. Chief Financial Officer Purchase +97,561 $2.05 $200K 151,231
2024-12-05 James Andrea S. Chief Financial Officer Purchase +20,000 $2.29 $46K 53,670
2024-10-11 James Andrea S. Chief Financial Officer Grant or award · Options to Purchase Common Stock +200,000 200,000
2024-10-11 James Andrea S. Chief Financial Officer Grant or award · Restricted Stock Units +100,000 100,000
2024-10-02 James Andrea S. Chief Financial Officer Purchase +33,670 $2.97 $100K 33,670
2024-06-20 James Andrea S. Chief Financial Officer Grant or award · Option to Purchase Common Stock +200,000 200,000
2024-06-20 James Andrea S. Chief Financial Officer Grant or award · Restricted Stock Units +100,000 300,000

Page 1 of 1 · 17 trades